Public annual accounts

DNA financials

Name: DNA financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for DNA, with comparable measures and links to available source documents.

Company overview

Registry number

0735910492

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

Latest movements for DNA

2025 versus 2024

Operating line: €3,091,374
EBITDA: -€124,741
Total assets: €654,422
Equity: -€357,893

EBITDA margin -4% · Equity ratio -54.7%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€3,091,374	-€124,741	€654,422	-€357,893	-
202431 Dec 2024	€2,439,755	-€64,586	€495,650	-€193,365	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report